You have found 219 entries after clicking on a search link (usually the MORE information link) in a matrix cell. Sorted by the main topic addressed, the list shows in orange the type of entry, year the original document was published (or if one of our own documents, the year last updated), and the type of file you will download when you click on the title. In blue is the document’s title followed by a brief description.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
Re-order the list by the most recently added or updated entries or by the most recently published documents
If you have not found what you want you could:
Select from the full range of topics and search options available on our topic search page.
Instead try a free text search for documents which contain the words you specify.
Or try browsing back issues of the magazine or recent bulletins.
Documents are regularly added. Use the e-mail update service to monitor additions.
Try the information services provided by partner agencies.
Tried everything? E-mail the Findings editor for help by clicking on this logo
REVIEW 2021 HTM file
Engaging the family in the care of young adults with substance use disorders
[Consultation draft subject to amendment and correction.] A group of paediatric addiction medicine experts in the US review the evidence base and agree on practice considerations for engaging the family in the care of young adults with substance use disorders, concluding that the more family members are able to engage in activities to improve their own health, the more likely the health of the entire family system will improve.
[Consultation draft subject to amendment and correction.] A window into Home Office-approved drug safety testing for people using or intending to use illicit drugs: a pilot project operating from a community substance misuse service in North Somerset.
[Consultation draft subject to amendment and correction.] A group of paediatric addiction medicine experts in the US review the evidence base and agree on practice considerations for the care and treatment of young adults with co-occurring mental health and substance use problems. The principles of care identified in this document highlight the need for collaborative care, the use of both trauma-specific and trauma-informed interventions, and continual reassessment of symptoms and goals throughout treatment.
DOCUMENT 2012 HTM file
Drug misuse statistics Scotland 2011
Statistical picture of drug misuse in Scotland in 2010/11 including treatment and criminal justice caseloads and health impacts, plus trends over recent years.
DOCUMENT 2010 HTM file
Drug misuse statistics Scotland 2010
Statistical picture of drug misuse in Scotland in 2009 and 2010 including treatment and criminal justice caseloads and health impacts, plus trends over recent years.
Sets out the structure and objectives of the public health system for England effective from April 2013 and how progress against these objectives will be measured, including addiction treatment completions, alcohol-related hospital admissions, and prisoners identified as needing treatment for alcohol/drug problems.
STUDY 2014 HTM file
Drugs: international comparators
After seeing how drug policy worked overseas, UK government ministers and officials returned saying, “there is no apparent correlation between the ‘toughness’ of a country’s approach and the prevalence of adult drug use”, and that “better health outcomes for drug users cannot be shown to be a direct result of the enforcement approach”.
Taking a public health and human rights-based approach, the 2018 strategy from Scotland strives to improve citizens’ lives by preventing and reducing the harms of drinking and drug use.
MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell D1: Organisational functioning; Reducing harm
Seminal and key studies on the influence of the organisation on reducing drug-related harm.
Substance use treatment commissioned on a payment-by-results basis in England has been linked to higher rates of in-treatment abstinence and non-injecting than other commissioning models, but lower rates of treatment initiation and completion. Is this enough to support the policy?
Select search results pageNEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22